- 7 -



          P.   Acceptance of Interim Financial Report for the
University of Kentucky for the Eight Months Ended February 28. 1993
(FCR 1)

          Mr. Hardymon, Chairperson of the Finance Committee, reported
that the Finance Committee met on the morning of April 6 and considered
eleven items to be presented for action. He stated that the first item
is the consolidated financial report for the first eight months of the
fiscal year. He reported that realized income and expenditures are on
target and the Committee recommends approval. On motion made by Mr.
Chellgren and seconded by Mr. Shoop, FCR I was approved. (See FCR 1 at
the end of the Minutes.)

          Q.    Disposal of Personal Property (FCR 2)

          Mr. Hardymon stated that FCR 2 is disposal of personal
property. He said that this is a regular event that takes place under
the guidance of the standards required and the Board is asked to
authorize the sale or disposal of all personal property which is not
needed by the institution. He reviewed the items in Exhibit I and
recommended approval.  Mr. Wilcoxson moved approval.  His motion,
seconded by Dr. Meriwether, passed. (See FCR 2 at the end of the
Minutes.)

          R.    Report of Leases (FCR 3)

          Mr. Hardymon stated that FCR 3 is a report of two leases under
$30,000. He reminded the Board that leases under $30,000 can be
authorized by the President and are reported to the Finance Committee
and the Board for acceptance. He explained that FCR 3 involves two
small leases for land for tobacco experiments in other parts of the
state and recommended approval. Mr. Clay moved approval of FCR 3. His
motion was seconded by Dr. Meriwether and carried. (See FCR 3 at the
end of the Minutes.)

          S.   Approval of Lege Addendum (FOR 4) and Approval of
Lease Addendum (FCR 5)

          Mr. Hardymon reported FCR 4 and FCR 5 are very similar items.
They are for lease addendums between Hazard Community College and
Appalachian Regional Healthcare and Medical Center Rural Health and
Appalachian Regional Healthcare. He reviewed the square footage and
costs involved in each addendum and recommended approval of both items.

          Mr. Rose moved approval of FCR 4. Mr. Shoop seconded the
motion and it carried. (See FCR 4 at the end of the minutes.)

          Mr. Chellgren then moved approval of FCR 5. His motion was
seconded by Mr. Clay and passed.  (See FCR 5 at the end of the Minutes.)

          T.    Patent Aaaignment (FCR 6)

          Mr. Hardymon reported that FCR 6 is a patent involving certain
improvements in Permeable, Non-Irritating Prodrugs of Nonsteroidal,
Anti-inflammatory Agents. He said that it is in accord with usual